Local Actions of Endogenous Angiotensin II in Injured Glomeruli

Journal of the American Society of Nephrology

Volumn 15, Issue 5, 2004, Pages 1268-1276

  Ma, Ji ^a,b,c   Matsusaka, Taiji ^a,c   Yang, Haichun ^b   Kawachi, Hiroshi ^d   Shimizu, Fujio ^d   Isaka, Yoshitaka ^e   Imai, Enyu ^e   Kon, Valentina ^c   Ichikawa, Iekuni ^a,c  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b FUDAN UNIVERSITY   (China)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^d NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^e OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CELL PROLIFERATION; CONTROLLED STUDY; DRUG MECHANISM; ELECTROPORATION; GLOMERULUS; IMMUNOHISTOCHEMISTRY; KIDNEY INJURY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

EID: 1942474488     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ASN.0000125675.70674.0F     Document Type: Article

References (44)

1. Matsusaka T, Hymes J, Ichikawa I: Angiotensin in progressive renal diseases: Theory and practice. J Am Soc Nephrol 7: 2025-2043, 1996
2. Matsusaka T, Katori H, Inagami T, Fogo A, Ichikawa I: Communication between myocytes and fibroblasts in cardiac remodeling in angiotensin chimeric mice. J Clin Invest 103: 1451-1458, 1999
3. Lafayette RA, Mayer G, Park SK, Meyer TW: Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass. J Clin Invest 90: 766-771, 1992
4. Bidani AK, Griffin KA, Bakris G, Picken MM: Lack of evidence of blood pressure-independent protection by renin-angiotensin system blockade after renal ablation. Kidney Int 57: 1051-1661, 2000
5. Griffin KA, Abu-Amarah I, Picken M, Bidani AK: Renoprotection by ACE inhibition or aldosterone blockade is blood pressure-dependent. Hypertension 41: 201-206, 2003
6. Kurtz TW: False claims of blood pressure independent protection by blockade of the renin angiotensin aldosterone system. Hypertension 41: 193-196, 2003
7. Takaya J, Matsusaka T, Katori H, Fogo A, Ichikawa I: Systemic angiotensin has no local impact on the DNA synthesis in the glomerulus in vivo [Abstract]. J Am Soc Nephrol 11: 372A, 2000
8. Dechow C, Morath C, Peters J, Lehrke I, Waldherr R, Haxsen V, Ritz E, Wagner J: Effects of all-trans retinoic acid on renin-angiotensin, system in rats with experimental nephritis. Am J Physiol Renal Physiol 281: F909-F919, 2001
9. Ballermann BJ, Skorecki KL, Brenner BM: Reduced glomerular angiotensin II receptor density in early untreated diabetes mellitus in rat. Am J Physiol 247: F110-F116, 1984
10. Wilkes BM: Reduced glomerular antiotensin II receptor density in diabetes mellitus in the rat: Time course and mechanism. Endocrinology 120: 1291-1298, 1987
11. O'Brien RC, Cooper ME, Jerums G, Doyle AE: The effects of perindopril and triple therapy in a normotensive model of diabetic nephropathy. Diabetes 42: 604-609, 1993
12. Ma L-J, Fogo A: Model of robust induction of glomerulosclerosis in mice: Importance of genetic background. Kidney Int 64: 350-5, 2003
13. Peters H, Border WA, Noble NA: Targeting TGF-beta overexpression in renal disease: Maximizing the antifibrotic action of angiotensin II blockade. Kidney Int 54: 1570-1580, 1998
14. Nakamura T, Obata J, Kimura H, Ohno S, Yoshida Y, Kawachi H, Shimizu F: Blocking angiotensin II ameliorates proteinuria and glomerular lesions in progressive mesangioproliferative glomerulonephritis. Kidney Int 55: 877-889, 1999
15. Ambühl P, Gyurko R, Phillips MI: A decrease in angiotensin receptor binding in rat brain nuclei by antisense oligonucleotides to the angiotensin AT1 receptor. Regulatory Peptides 59: 171-182, 1995
16. Tsujie M, Isaka Y, Nakamura H, Imai E, Hori M: Electroporation-mediated gene transfer that targets glomeruli. J Am Soc Nephrol 12: 949-954, 2001
17. Cheng QL, Orikasa M, Morioka T, Kawachi H, Chen XM, Oite T, Shimizu F: Progressive renal lesions induced by administration of monoclonal antibody 1-22-3 to unilaterally nephrectomized rats. Clin Exp Immunol 102: 181-185, 1995
18. th, Harris RC, Mckanna JM, Inagami T, Hogan BL, Fogo A, Ichikawa I: Angiotensin induces the urinary peristaltic machinery during the perinatal period. J Clin Invest 102: 1489-1997, 1998
19. van Krimpen C, Smits JF, Cleutjens JP, Debets JJ, Schoemaker RG, Struyker-Boudier HA, Bosman FT, Daemen MJ: DNA synthesis in the non-infarcted cardiac interstitium after left coronary artery ligation in the rat: effects of captopril. J Mol Cell Cardiol 23: 1245-1253, 1991
20. Gavrieli Y, Sherman Y, Ben-Sasson SA: Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119: 493-501, 1992
21. Thomas GL, Yang B, Wagner BE, Savill J, El Nahas AM: Cellular apoptosis proliferation in experimental renal fibrosis. Nephrol Dial Transplant 13: 2216-2226, 1998
22. Yoshimura A, Inui K, Nemoto T, Uda S, Sugenoya Y, Watanabe S, Yokota N, Taira T, Iwasaki S, Ideura T: Simvastatin suppresses glomerular cell proliferation and macrophage infiltration in rats with mesangial proliferative nephritis. J Am Soc Nephrol 9: 2027-2039, 1998
23. Kiyama S, Nanishi F, Tomooka S, Okuda S, Onoyama K, Fujishima M: Inhibitory effects of antihypertensive drugs on mesangial cell proliferation after anti-thymocyte serum (ATS)-induced mesangiolysis in spontaneously hypertensive rats. Life Sci 54: 1891-1900, 1994
24. Hugo C, Shankland SJ, Bowen-Pope DF, Couser WG, Johnson RJ: Extraglomerular origin of the mesangial cell after injury. A new role of the juxtaglomerular apparatus. J Clin Invest 100: 786-794, 1997
25. Zoja C, Abbate M, Coma D, Capitanio M, Donadelli R, Bruzzi I, Oldroyd S, Benigni A, Remuzzi G: Pharmacologic control of angiotensin II ameliorates renal disease while reducing renal TGF-beta in experimental mesangioproliferative glomerulonephritis. Am J Kidney Dis 31: 453-463, 1998
26. Kobayashi H, Orikasa M, Naito M, Kawasaki K, Oite T, Kawachi H, Yamashita A, Takeya M, Nihei H, Shimizu F: Detailed analysis of phenotypes of macrophages infiltrating glomeruli in rat anti-Thy-1 nephritis. Nephron 77: 333-339, 1997
27. Okuda S, Languino LR, Ruoslahti E, Border WA: Elevated expression of transforming growth factor-beta and proteoglycan production in experimental glomerulonephritis. Possible role in expansion of the mesangial extracellular matrix. J Clin Invest 86: 453-462, 1990
28. Wakasugi M, Kawachi H, Omori S, Takagi J, Nishi S, Arakawa M, Shimizu F: Expression of the molecule detectable by anti-propolypeptide of von Willebrand factor antibody in rat mesangial cells in anti-Thy 1.1 mAb 1-22-3 induced glomerulonephritis: A marker of injured mesangial cells. Nephron 82: 338-47, 1999
29. Paxton WG, Runge M, Horaist C, Cohen C, Alexander RW, Bernstein KE: Immunohistochemical localization of rat angiotensin II AT1 receptor. Am J Physiol 264: F989-F995, 1993
30. Harrison-Bernard LM, Navar LG, Ho MM, Vinson GP, el-Dahr SS: Immunohistochemical localization of ANG II AT1 receptor in adult rat kidney using a monoclonal antibody. Am J Physiol 273: F170-F177, 1997
31. Kakinuma Y, Fogo A, Inagami T, Ichikawa I: Intrarenal localization of angiotensin II type 1 receptor mRNA in the rat. Kidney Int 43: 1229-1235, 1993
32. Wolf G, Neilson EG: Angiotensin II as a renal growth factor. J Am Soc Nephrol 3: 1531-1540, 1993
33. Panzer U, Schneider A, Wilken J, Thompson DA, Kent SB, Stahl RA: The chemokine receptor antagonist AOP-RANTES reduces monocyte infiltration in experimental glomerulonephritis. Kidney Int 56: 2107-2115, 1999
34. Taal MW, Chertow GM, Rennke HG, Gumani A, Jiang T, Shahsafaei A, Troy JL, Brenner BM, Mackenzie HS: Mechanisms underlying renoprotection during renin-angiotensin system blockade. Am J Physiol Renal Physiol 280: F343-F355, 2001
35. Raij L, Chiou XC, Owens R, Wrigley B: Therapeutic implications of hypertension-induced glomerular injury. Comparison of enalapril and a combination of hydralazine, reserpine, and hydrochlorothiazide in an experimental model. Am J Med 79: 37-41, 1985.
36. Hamilton TA, Handa RK, Harding JW, Wright JW: A role for the angiotensin IV/AT4 system in mediating natriuresis in the rat. Peptides 22: 935-944, 2001
37. Miller MJ, Scroop GC: Disappearance of angiotensin II and noradrenaline from the renal and femoral circulations of the dog. Clin Sci (Lond) 58: 29-35, 1980
38. Wenzel UO, Thaiss F, Helmchen U, Stahl RAK, Wolf G: Angiotensin II infusion ameliorates the early phase of a mesangioproliferative glomerulonephritis. Kidney Int 61: 1020-1029, 2002
39. Wenzel UO, Thaiss F, Panzer U, Schneider A, Schwietzer G, Helmchen U, Stahl RA: Effect of renovascular hypertension on experimental glomerulonephritis in rats. J Lab Clin Med 134: 292-303, 1999
40. Ruiz-Ortega R, Esteban V, Suzuki Y, Ruperez M, Mezzano S, Ardiles L, Justo P, Ortiz A, Egido J: Renal expression of angiotensin type 2 (AT2) receptors during kidney damage. Kidney Int 64:S21-S26, 2003
41. Shimizu A, Kitamura H, Masuda Y, Ishizaki M, Sugisaki Y, Yamanaka N: Apoptosis in the repair process of experimental proliferative glomerulonephritis. Kidney Int 47: 114-121, 1995
42. Kanai H, Okuda S, Kiyama S, Tomooka S, Hirakata H, Fujishima M: Effects of endothelin and angiotensin II on renal hemodynamics in experimental mesangial proliferative nephritis. Nephron 64: 609-614, 1993
43. Ostendorf T, Kunter U, van Roeyen C, Dooley S, Janjic N, Ruckman J, Eitner F, Floege J: The effects of platelet-derived growth factor antagonism in experimental glomerulonephritis are independent of the transforming growth factor-beta system. J Am Soc Nephrol 13: 658-667, 2002
44. Haraguchi M, Border WA, Huang Y, Noble NA: t-PA promotes glomerular plasmin generation and matrix degradation in experimental glomerulonephritis. Kidney Int 59: 2146-2155, 2001